Ebmeier K P, Besson J A, Crawford J R, Palin A N, Gemmel H G, Sharp P F, Cherryman G R, Smith F W
Acta Psychiatr Scand. 1987 May;75(5):549-56. doi: 10.1111/j.1600-0447.1987.tb02832.x.
White matter lesions and T1 changes were identified using NMR and then compared between groups of patients suffering from dementia of the Alzheimer type (DAT), Multiple infarct dementia (MID) and normal controls. All DAT and MID patients were also imaged with a gamma camera using 123Iodo-n-isopropyl-amphetamine, a radiopharmaceutical whose uptake in the brain follows the regional blood flow. While NMR was not able to differentiate between DAT and MID, 19 out of 21 DAT patients compared to four out of 18 MID patients showed bilateral parietal lesions on IMP scans.
使用核磁共振成像（NMR）识别白质病变和T1变化，然后在患有阿尔茨海默型痴呆（DAT）、多发梗死性痴呆（MID）的患者组与正常对照组之间进行比较。所有DAT和MID患者还使用γ相机，通过123碘-n-异丙基安非他明进行成像，123碘-n-异丙基安非他明是一种放射性药物，其在大脑中的摄取遵循局部血流情况。虽然核磁共振成像无法区分DAT和MID，但在IMP扫描中，21例DAT患者中有19例与18例MID患者中的4例相比，显示出双侧顶叶病变。
